WhiteLab Genomics
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
$26MSeries B
LeadActivity from announced rounds
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
Streaming security operations that detect threats in motion and route data across an organisation’s tools.
Builds AI agents for institutional investors to surface market-moving signals in public markets
An open-source vector search engine.
Provides AI-native IP platform for enterprises to manage IP lifecycle
Develops secure software delivery for national security mission systems
Deepgram provides real-time voice APIs for speech recognition, speech synthesis and voice AI applications.